Current Intelligence Bulletin 27: Chloroethanes Review of Toxicity

Errata

In Bulletins #22 through #25 it was stated that the NIOSH National Occupational Hazard Survey (NOHS) had included “over 500,000 employees at 4,775 facilities.” Actually the Survey included nearly 900,000 employees at 4,636 facilities.

In Bulletin #23 NIOSH erroneously listed Dowfume^® MC-2 as a synonym for ethylene dibromide. Dow Chemical USA has advised NIOSH that Dowfume^® MC-2 actually is 98% methyl bromide and 2% chloropicrin.

Chloroethanes: Review of Toxicity

The National Institute for Occupational Safety and Health (NIOSH) recommends that it would be prudent to handle 1,2-dichloroethane (ethylene dichloride); 1,1,2- trichloroethane; 1,1,2,2-tetrachloroethane; and hexachloroethane in the workplace as if they were human carcinogens. This recommendation is based primarily on consideration of National Cancer Institute (NCI) data indicating that laboratory animals administered these compounds experienced a statistically significant excess of cancer as compared to control animals.^1-4 Additionally, NIOSH recommends that five other chloroethane compounds: chloroethane^* (ethyl chloride); 1,1-dichloroethane; 1,1,1-trichloroethane (methyl chloroform); 1,1,1,2-tetrachloroethane; and pentachloroethane be closely monitored for carcinogenic effects in humans and/or laboratory animals. These five should also be treated in the workplace with caution because of their relation to the four chloroethanes shown to be carcinogenic in laboratory animals.

This Current Intelligence Bulletin summarizes information on some of the similarities and dissimilarities within the chloroethane group. NIOSH is concerned about the carcinogenic potential of chloroethanes based on emerging data from the NCI bioassay program. Concern for the carcinogenic potential of all members of the chloroethane series is based upon structural similarities within the group as well as the structural similarities to other carcinogenic organochlorine compounds. Extreme care must be used when selecting possible substitutes, and the alternatives should be fully evaluated with regard to human effects.

At present, NIOSH is not aware of any evidence associating chloroethane compounds with an increased risk of cancer in man. However, animal studies are valuable in helping identify human carcinogens. Substances that cause cancer in experimental animals must be considered a potential cancer risk in man. Safe levels of exposure to carcinogens have not been demonstrated, but lowered exposure to carcinogens decreases the probability of cancer development.

NIOSH issued Current Intelligence Bulletin #25 (April 1978), recommending that ethylene dichloride (1,2-dichloroethane) be handled in the workplace as if it were a human carcinogen.⁵ NIOSH is now distributing Bulletin #27 to advise of additional findings of the NCI chloroethane bioassays, other pertinent data, and possible implications for occupational health. Also included are “Suggested Guidelines for Controlling Employee Exposure to Chloroethanes.” NIOSH requests that producers, distributors, professional associations, and unions transmit the information in this Bulletin to their custorners, employees, associates and members.

Table 1. Summary of Some of the Industries and Occupations Which Use Chloroethanes.^a

(a) 1,1,1,2-tetrachloroethane and pentachloroethane were not mentioned in the NOHS survey⁶ [return to table]
(b) These are standard industrial titles from the Standard Industrial Classification Manual⁷ [return to table]
(c) These are standard occupational titles from the Burea of the Census⁸ [return to table]

Background

Chloroethanes are chlorinated organic compounds structurally related to ethane in which one or more of the hydrogen atoms have been replaced by a chlorine atom or atoms. Monochloroethane, for example, is shown to result from the replacement of one hydrogen atom in ethane by a chlorine atom.

At room temperature monochloroethane is a gas, hexachloroethane is a solid, and the seven other chloroethanes are liquids. Some of the chloroethanes are manufactured on a large scale and used extensively because of their low cost and excellent solvent properties. They are used as solvents and in degreasing agents, cutting fluids, fumigants, and in the manufacture of plastics, textiles, and other chemicals. Table 1 summarizes the major industries and occupations in which workers are potentially exposed to chloroethanes.

From 1972-1974, NIOSH conducted the NIOSH National Occupational Hazards Survey (NOHS), on a sample of about 900,000 employees at 4,636 facilities, in order to determine the potential for worker exposure to chemicals and physical agents. NOHS algorithms used Bureau of the Census 1970 population counts to permit extrapolation from the sample to the United States worker population of 1970. A total of over 3 million workers were estimated to be potentially exposed to one or more chloroethanes. Table 2 presents a summary of NOHS estimates of worker exposure to chloroethanes and some production figures.^6,9,40

Table 2. Chloroethane Exposures and Production.^6,9,40

(a) NOHS estimates not available [return to table]
(b) does not appear to be commercially produced in the United States [return to table]
(c) direct production information not available [return to table]
(d) 73O,OOO kg were imported in 1976 [return to table]

Summaries of the current Department of Labor – Occupational Safety and Health Administration (OSHA) exposure standards¹⁰ and NIOSH recommended exposure standards for the chloroethane compounds are given in Table 3.

Table 3. Chloroethane Exposure Standards.

* NIOSH has tentative plans for a Criteria Document for a Recommended Standard for this substance

The OSHA exposure standards and the NIOSH recommended standards and control measures for the chloroethanes were developed before the carcinogenic potential of these compounds was recognized. Therefore, an assessment of the carcinogenicity of these compounds was not included. The levels currently recommended or adopted may not provide adequate protection from potential carcinogenic effects.

Laboratory Animal Studies

Carcinogenicity

As of July 1978, four of the eight chloroethanes selected by NCI for testing have been shown to be carcinogenic in laboratory animals. The results of the bioassays^1-4,14 are summarized in Table 4. Each compound was studied separately in male and female Osborne-Mendel rats and male and female B⁶C³F¹ mice. Each experiment consisted of a high dose and a low dose group of 50 animals each. Twenty animals of each species/sex combination served as untreated controls and 20 animals of each species/sex combination served as vehicle controls. The chloroethane compounds were administered to the test animals in a corn oil vehicle by gastric intubation (stomach tube) five days a week for 78 weeks. The vehicle controls were intubated with pure corn oil at the same rate as the high dose animals.

Table 4. Summary of NCI Chlorothane Bioassay Results as of July 1978 ^1-4,14

The National Cancer Institute has concluded that under the conditions of the bioassay 1,2-dichloroethane; 1,1,2-trichloroethane; 1,1,2,2-tetrachloroethane; and hexachloroethane are carcinogenic in mice, inducing liver cancer in both sexes.^1-4 Additionally, results of the NCI bioassay of 1,2-dichloroethane indicate that this compound also causes cancer in male and female rats. In mice 1,1,2-trichloroethane was also associated with increased adrenal pheochromocytoma, a tumor which gives rise to high blood pressure and hyperglycemia. Toxic kidney damage was observed in all groups of both mice and rats treated with hexachloroethane.⁴

Although the occurence of cancer in mice is highly significant, the results do not provide conclusive evidence that 1,1,2-trichloroethane; 1,1,2,2-tetrachloroethane; or hexachloroethane cause cancer in rats. A statistically significant association between increased dosage and accelerated mortality was observed in rats treated with hexachloroethane. NCI has concluded that early mortality may have obscured a carcinogenic effect in these animals.

The National Cancer Institute is currently conducting bioassays of pentachloroethane and 1,1,1,2-tetrachloroethane.¹⁴ They are also retesting 1,1-dichloroethane and 1,1,1-trichloroethane because the previous tests were inconclusive; low survival rates complicated the interpretation of the bioassay results. Monochloroethane has not yet been tested.

Other Adverse Effects

All of the chloroethane compounds are known to cause central nervous system (CNS) depression in laboratory animals. This is usually expressed as abnormal weakness, intoxication, restlessness, irregular respiration, muscle incoordination, and unconsiousness. Chloroethanes are generally irritating to the eyes and skin. Damage to the liver and/or kidney has been demonstrated in various animal species following exposure to these compounds.¹⁵

It has been reported that some of the chloroethanes and their metabolites are mutagenic in bacterial systems.^3,16 Mutagenic activity per se, should be considered a substantial liability. In addition, research suggests a correlation between mutagenicity in some bacterial strains and carcinogenicity in higher animals. Other adverse effects of the chloroethanes may vary from one compound to another. Table 5 summarizes some of the toxicological studies in animal systems.

Table 5. Some Adverse Effects of Chloroethanes
Reported in Animal Studies ^{5,11-13,17-37}

Human Toxicity

Although chloroethanes have been associated with cancer in laboratory animals, NIOSH is unaware of any definitive evidence indicating that chloroethanes are carcinogenic in humans. However, the chloroethanes have long been known to be capable of producing harmful local and systemic effects. As summarized in Tables 6 and 7, the chloroethanes may affect a variety of human organs or systems. The effects of chloroethane exposure vary from one compound to another, but, most are known to effect the central nervous system (CNS). In many instances, the clinical manifestations and laboratory findings associated with chloroethane toxicity are similar for the major routes of entry: inhalation, skin absorption, and ingestion. Liver and/or kidney injury, pulmonary irritation, and damage to the blood-forming system have been associated with inhalation of chloroethanes. Repeated or prolonged skin exposure can defat the skin and cause dermatitis.

In addition to the toxic effects of chloroethanes and their metabolites, the oxidative decomposition of products produced in the presence of open flames, hot metals, or lighted cigarettes should be taken into account. The chloroethane compounds may degrade to phosgene, hydrogen chloride and dichloroacetylene. Phosgene is considered to be dangerous to life in 30 to 60 minutes at 12.5 ppm.³⁷

Table 6. Adverse Effects of Chloroethanes on
Human Organs and Systems ^{5,11-13,39-40 *}

* adverse human health effects have not been reported to NIOSH for 1,1,2-trichloroethane, 1,1,1,2-tetrachloroethane, and pentachloroethane[return to table]

Table 7. Specific Adverse Effects of Chloroethanes on Humans, by System.^{5,11-13,37-39}

NIOSH Recommendation

Animal studies are valuable in helping identify human carcinogens. Substances that cause cancer in experimental animals must be considered a potential cancer risk in man. Although safe levels of exposure to carcinogens have not yet been demonstrated decreasing exposure to carcinogens does reduce their probability of initiating cancer development.

As an interim and prudent measure while the carcinogenicity of chloroethanes is being further evaluated NIOSH recommends that occupational exposure to 1,2-dichloroethane; 1,1,2-trichloroethane, 1,1,2,2-tetrachloroethane, and hexachloroethane be minimized. Exposures should be limited to as few employees as possible, while minimizing workplace exposure levels with engineering and work practice controls. Additionally, monochloroethane; 1,1-dichloroethane; 1,1,1-trichloroethane; 1,1,1,2-tetrachloroethane; and pentachloroethane should be treated in the workplace with caution.

[signature]
J. Michael Lane, M.D.
Acting Director

Note

* to be referred to as monochloroethane in this Bulletin[return to text]

References

2. National Cancer Institute. Bioassay of 1,2-Dichloroethane for Possible Carcinogenicity. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, Carcinogenesis Testing Program, DHEW Publication No. (NIH) 78-1305, January 10, 1978.
3. National Cancer Institute. Bioassay of 1,1,2-Trichloroethane for Possible Carcinogenicity. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, DHEW Publication No. (NIH) 78-1324, 1978.
4. National Cancer Institute. Bioassay of 1,1,2,2-Tetrachloroethane for Possible Carcinogenicity. U.S. Department of Health, Education and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, DHEW Publication No. (NIH) 78-827, 1978.
5. National Cancer Institute. Bioassay of Hexachloroethane for Possible Carcinogenicity. U.S. Department of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, DHEW Publication No. (NIH) 78-1318, 1978.
6. National Institute for Occupational Safety and Health. NIOSH Current Intelligence Bulletin #25, Ethylene Dichloride. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 78-149, April 19, 1978.
7. National Institute for Occupational Safety and Health. National Occupational Hazard Survey Volume I Survey Manual. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW Publication No. (NIOSH) 74-l27, 1974.
8. Bureau of the Budget. Standard Industrial Classification Manual. U.S. Executive Office of the President, Bureau of the Budget, 1967.
9. U.S. Bureau of the Census. 1970 Census of Population, Alphabetical Index of Industries and Occupations. U.S. Department of Commerce, Bureau of the Census, 1971.
10. Private Correspondence from SRI International, Menlo Park, California, June 29, 1978.
11. United States Department of Labor, Occupational Safety and Health Administration. General Industry Standards (29 Code of Federal Regulations 1910), January, 1976.
12. National Institute for Occupational Safety and Health. Criteria for a Recommended Standard . . . . Occupational Exposure to Ethylene Dichloride (1,2-Dichloroethane). U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 76-139, March, 1976.
13. National Institute for Occupational Safety and Health. Criteria for a Recommended Standard …. Occupational Exposure to 1,1,1-Trichloroethane (Methyl Chloroform). U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 76-184, July, 1976.
14. National Institute for Occupational Safety and Health. Criteria for a Recommended Standard . . . . Occupational Exposure to 1,1,2,2-Tetrachloroethane. U.S. Department Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 77-121, December, 1976.
15. National Cancer Institute. Chemicals Being Tested for Carcinogenicity by the Carcinogenesis Testing Program. Division of Cancer Cause and Prevention, National Cancer Institute, June 1, 1978.
16. Sax, N.I.: Dangerous Properties of Industrial Materials. New York, Van Nostrand Reinhold Company, 1975.
17. Fishbein, L.: Industrial mutagens and potential mutagens I. halogenated aliphatic derivatives. Mutation Research 32:2176-308, 1976.
18. Shmuki, L.M.: The effect of chronic exposure to low concentrations of chlorinated ethane-series hydrocarbons on specific and nonspecific immunological response in animals under experimental conditions. Gigiena Truda I Professionalyne Zabolevania (8): 38-43, 1977.
19. McCann, J., Simmon, V., Streitwieserp D., Ames, B.N.: Mutagenicity of chloroacetaldehyde, a possible metabolic product of 1,2-dichloroethane (ethylene dichloride), chlorethanol (ethylene chlorohydrin), vinyl chloride, and cyclophosphamide. Proceedings of the National Academy of Sciences of the U.S.A. 72(8): 3190-3193, August, 1975.
20. Smyth, H.F., Cummings, D.E.: Halogenated hydrocarbons: I. aliphatic. IN: Patty, F.A. Industrial Hygiene and Toxicology Second Revised Edition, Volume II. New York, John Wiley and Sons, Inc., 1963.
21. Schwetz, B.A., Leong, B.K., Gehring, P.J.: Embryo and fetotoxicity of inhaled carbon tetrachloride, 1,1-dichloroethane and methyl ethyl ketone in rats. Toxicology and Applied Pharmacology 28(3): 452-464, June, 1974.
22. Hofmann, H.T., Birnstiel, H., Jobst, P.: Zur Inhalation Toxicitat von 1,1 und 1,2-Dichorathan (on the inhalation toxicity of 1,1- and 1,2-dichloroethane). Archiv fur Toxikologie 27(3): 248-265, 1971.
23. Plaa, G.L., Evans, E.A., Hine, C.H.: Relative hepatotoxicity of seven halogenated hydrocarbons. Journal of Pharmacology and Experimental Therapeutics 123: 224-229, 1958.
24. Gradiski, D., Magadur, J.L.: Toxicite’ Compare’ des Principaux Solvants Chlore’ Aliphatiques. European Journal of Toxicology 7(4): 247-254, July- August, 1974.
25. Wahlberg, J.E.: Percutaneous toxicity of solvents. A comparative investigation in the guinea pig with benzene, toluene and 1,1,2-trichloroethane. Annals of Occupational Hygiene 19: 115-119, 1976.
26. Watrous, W.M., Plaa, G.L.: The nephrotoxicity of single and multiple doses of aliphatic chlorinated hydrocarbon solvents in male mice. Toxicology and Applied Pharmacology 23: 640-649, 1972.
27. Kronevi, T., Wahlberg, J., Holmberg, B.: Morphological lesions in guinea pigs during skin exposure to 1,1,2-trichloroethane. Acta Pharmalogica et Toxicologica 41: 298-305, 1977.
28. Truhaut, R., Lich, N.P., Dutertre-Catella, H., Molas, G., Huyen, V.N.: Toxicological study of 1,1,1,2-tetrachloroethane. Archives des Maladies Professionnelles, de Medecine du Travail et de Securite 35(6): 593608, 1974.
29. Truhaut, R., Lich, N.P., Le Quang Thaun, N.T., Dutertre-Catella, H.: Etude de Quelques Activites Enzymatiques Se’ et de Quelques Constituants Biochimiques Sanquins, Au Cours Des Intoxications Subaiques Avec Le Tetrachloro 1,1,1,2 Ethane Chez Le Lapin (Study of some serum enzyme activities and blood biochemical constituents during subacute intoxications with 1,1,1,2-tetrachloroethane in the rabbit). European Journal of Toxicology 6(2): 81-849 1973.
30. Truhaut, R., Thevenin, M., Warnet, J.M., Claude, J.R., Lich, N.P.: Etude Biochimique Preliminaire de l’Hepatotoxicite Du Te/trachloro-1,1,1,2-Ethan Chez Le Rat Wistar. Influence Du Sexe. (Preliminary biochemical study of hepatotoxity of 1,1,1,2-tetrachloroethane in the Wistar rat). European Journal of Toxicology 8(3): 175-179, 1975.
31. Chieruttini, M.E., Franklin, C.S.: The toxicology of the tetrachlorethanes. British Journal of Pharmacology 57(3): 421, 1976.
32. Holmberg, B., Malmfors, T.: Cytotoxicity of some organic solvents. Environmental Research 7(2): 183-192, 1974.
33. Truhaut, R., Lich, P.N.: Transformations Metaboliques Du Tetrachloro 1,1,1,2 Ethane Chez Le Rat, Le Cobaye, et Le Lapin (Metabolic transformations of 1,1,1,2-tetrachloroethane in rats, guinea pigs and rabbits). European Journal of Toxicology 6(4-5): 211-217, 1973.
34. Yllner, S.: Metabolism of 1,1,1,2-tetrachloroethane in the mouse. Acta Pharmacoloica et Toxicologica 29(5-6): 471-480, 1971.
35. Vozovaya, M.A.: The effect of dichloroethane on the sexual cycle and embryogenesis of experimental animals. Akusk. Ginekol. (Moscow) 2:57-59, 1977,
36. Vozovaya, M.A.: The effect of small concentrations of benzene and dichloroethane separately and combined on the reproductive function of animals, Gig. Sanit. (Moscow) 6:100-102, 1976.
37. Vozovaya, M.A.: The effect of small concentrations of benzene, dichloroethane alone and combined, on the reproductive function of animals and the development of the progeny. Gig. Tr. Prof. Zabol. (Moscow) 7:20-23, 1975.
38. Patty, F.A., Fassett, D.W., Irish, D.D., Editors: Industrial Hygiene and Toxicology. Second Edition. New York, Interscience Publishers, 1963.
39. National Institute for Occupational Safety and Health. Occupational Diseases: A Guide to Their Recognition. U.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, National Institute for Occupational Safety and Health, DHEW (NIOSH) Publication No. 77-181, June,1977.
40. Gosselin, R.E., Hodge, H.C., Smith, R.P., Gleason, M.N., Editors: Clinical Toxicology of Commercial Products: Acute Poisoning. Fourth Edition. Baltimore, The Williams and Wilkins Co., 1976.
41. U.S. International Trade Commission. Synthetic Organic Chemicals, United Production and Sales, 1976. U.S. International Trade Commission, USITC Publication No. 833, 1976.

Suggested Guidelines for Controlling Employee Exposure to Chloroethanes

NIOSH recommends that it would be prudent to handle 1,2-dichloroethane (ethylene dichloride); 1,1,2-trichloroethane; 1,1,2,2-tetrachloroethane; and hexachloroethane in the workplace as if they were human carcinogens. Exposure to these chloroethanes should be limited to as few employees as possible, and workplace exposure levels should be minimized. The areas in which they are used should be restricted to only those employees essential to the process or operation and these employees should be adequately protected.

Additionally, NIOSH recommends that the other five chloroethane compounds: monochloroethane (ethyl chloride); 1,1-dichloroethane; 1,1,1-trichloroethane (methyl chloroform); 1,1,1,2-trichloroethane; and pentachloroethane should be treated in the workplace with caution because of their relation to the four chloroethanes shown to be carcinogenic in laboratory animals. These five chloroethanes should be closely monitored for carcinogenic effects in humans.

Exposure Monitoring

Detailed sampling and analytic methods for most of the chloroethane exposure measurements are described in the NIOSH Manual of Analytical Methods, Second Edition.¹ These are:

Initial and routine employee exposure surveys should be made by competent industrial hygiene and engineering personnel. These surveys are necessary to determine the extent of employee exposure and to ensure that controls are effective.

The NIOSH Occupational Exposure Sampling Strategy Manual² may be helpful in developing efficient programs to monitor employee exposures to chloroethanes. The manual discusses determination of the need for exposure measurements, selection of appropriate employees for exposure evaluation and selection of sampling times.

Employee exposure measurements should primarily consist of 8-hour TWA (time-weighted average) exposure estimates calculated from personal or breathing zone samples (air that would most nearly represent that inhaled by the employees). In addition, short term samples should be taken during periods of maximum expected exposure by using all available knowledge regarding the area, employee work procedures, and process. Area and source measurements may be useful to determine problem areas, processes and operations.

Controlling Employee Exposure

There are four basic methods of limiting employee exposure to chloroethanes. None of these is a simple industrial hygiene or management decision and careful planning and thought should be used prior to implementation.

Product Substitution

The substitution of an alternative material with a lower potential health risk is one method. However, extreme care must be used when selecting possible substitutes. Alternatives to chloroethanes should be fully evaluated with regard to possible human effects. Unless the toxic effects of the alternative have been thoroughly evaluated a seemingly safe replacement, possibly only after years of use, may be found to induce serious health effects.

Contaminant Controls

The most effective control of chloroethanes, where feasible, is at the source of contamination by enclosure of the operation and/or local exhaust ventilation. Guidelines for selected processes and operations can be found in the NIOSH Recommended Industrial Ventilation Guidelines.³

If feasible, the process or operation should be enclosed with a slight vacuum so that any leakage will result in the flow of external air into the enclosure.

The next most effective means of control would be a well designed local exhaust ventilation system that physically encloses the process as much as possible, with sufficient capture velocity to keep the contaminant from entering the work atmosphere. To ensure that ventilation equipment is working properly, effectiveness (e.g., air velocity, static pressure, or air volume) should be checked at least every three months. System effectiveness should be checked soon after any change in production, process, or control which might result in significant increases in airborne exposure to chloroethanes.

Employee Isolation

A third alternative is the isolation of employees. It frequently involves the use of automated equipment operated by personnel observing from a closed control booth or room. The control room is maintained at a greater air pressure than that surrounding the process equipment so that air flow is out of, rather than into, the room. This type of control will not protect employees who must do process checks, adjustments maintenance, and related operations.

Personal Protective Equipment

The least preferred method is the use of personal protective equipment. This equipment, which may include respirators, goggles, gloves, etc., should not be used as the only means to prevent or minimize exposure during routine operations.

Exposure to chloroethanes should not be controlled with the use of respirators except:

• During the time period necessary to install or implement engineering or work practice controls; or
• In work situations in which engineering and work practice controls are technically not feasible; or
• For maintence; or
• For operations which require entry into tanks or closed vessels; or
• In emergencies.

Only respirators approved by the National Institute for Occupational Safety and Health (NIOSH) under the provisions of Federal regulations 30 CFR 11 should be used. Refer to Cumulative Supplement June 1979 NIOSH Certified Equipment⁴ for a listing of NIOSH-approved respirators. Note that the use of faceseal coverlets or socks with respirators voids NIOSH approvals.

Quantitative faceseal fit test equipment (such as sodium chloride dioctyl phthalate, or equivalent) should be used. Refer to NIOSH’s A Guide to Industrial Respiratory Protection⁵ for guidelines on appropriate respiratory protection programs.

In addition, proper maintenance procedures, good housekeeping in the work area, and employee education are all vital aspects of a good control program. Employees should be informed as to the nature of the hazard, its control, and appropriate personal hygiene procedures.

References for Suggested Guidelines

2. NIOSH Manual of Analytical Methods, 2nd Edition, Vol. 1: GPO #017-033-00-267-3, $8.75: Vol. 2: GPO #017-033-00260-6, $9.75; Vol. 3: GPO #017-033-0247-9 $9.00.
3. NIOSH Occupational Exposure Sampling Strategy Manual, GPO #017-033-00247-9, $2.75.
4. NIOSH Recommended Industrial Ventilation Guidelines, GPO #017-033-00136-7, $3.90.
5. NIOSH Cummulative Supplement June 1977, NIOSH Certified Equipment, NIOSH #77-195, no charge.
6. A Guide to Industrial Respiratory Protection, GPO #017-033-00153-7, $2.30.